Duchenne Muscular Dystrophy (DMD) is the most common X-linked muscular disease affecting humans. The Golden Retriever Muscular Dystrophy model (GRMD) is consider the most suitable for several studies. This assay aims to quantify lymphocyte subpopulations CD4, CD5, and CD8, and standardize, the serum electrophoretic profile, to understand their contribution to the pathologic process in normal Golden Retriever dogs (GR group) and dystrophic´s (GRMD group), through the umbilical cord blood, in dogs aged from 2 to 3 months (GR II and GRMD II), and in dogs over 1 year of age (GR III and GRMD III). No significant differences were observed between the CD8+ lymphocyte subpopulations of the groups studied. The CD4+ and CD5+ lymphocyte subpopulations were significantly higher in the GRMD III group compared to the GR III group. Twenty-two different proteins in the gel were identified. The serum concentrations of the proteins belonging to the GR I and GRMD I groups were significantly lower than those of the other groups. We show that expression of acute phase proteins are worst during the aging of the dogs. We hope to expand knowledge to better understand the GRMD model and the translational data.
INTRODUCTION
Duchenne Muscular Dystrophy (DMD) is a neuromuscular alteration that can be hereditary in humans via recessive inheritance linked to the X chromosome, and it affects approximately one in every 3,500 males. Patients with DMD have an absence or a severely reduced level of dystrophin in the sarcoplasmic membrane, making it less stable, principally during contraction (Beenakker et DILAYLA K. DE ABREU et al. al. 2005) . Without dystrophin, the muscle becomes more susceptible to exercise-related injuries as evidenced by the rapid influx of calcium and the subsequent activation of proteases (Valentine et al. 1990) .
As a result, muscular inflammation, necrosis and the replacement of muscle tissue with fibrous and adipose tissue may occur, resulting in progressive muscle loss of both skeletal and cardiac muscle and damage to the nervous system (Valentine et al. 1990 ). Although these mutations are responsible for defects underlying the pathology of muscular dystrophies, other factors significantly contribute to the pathology, such as the involvement and activation of the immune system, leading to more changes in muscle homeostasis in addition to mechanical weakness.
The inflammatory process likewise alters cellular populations that work in the immune system by mediating the activation and directed migration of a number of cell populations, chiefly neutrophils and macrophages, from the blood stream to the locations of the injuries. Thus, the inflammatory process is vital because it guarantees that defensive cells and molecules rapidly concentrate in the damaged tissue (Abbas et al. 2008) .
Many studies are underway that aim to correlate lymphocyte subpopulations with various pathologies. In fact, T CD4+ lymphocytes play a central role in immune protection. In humans and mice, various subpopulations of lymphocytes -CD4
+ -Th and CD4 + -Treg -that support the immune response have been described. Recent studies provide preliminary information about the activity of inflammatory cells and skeletal muscle following acute skeletal damage. Specific antigens present to T and B lymphocytes play a critical role in the initial and progressive inflammatory myopathies (Marinaro et al. 2010 ).
According Jakubzick et al. (2004) , the IL-4 and IL-3 subpopulations of Th2 cytokines are potent fibrogenic factors, and the Th lymphocyte population may be involved in the late stages of DMD, in which fibrosis is prominent. In addition, regulatory T lymphocytes include cells that actively produce TGF-beta, another molecule with fibrotic action that is additionally known to limit the recruitment of myogenic precursor cells, complicating the repair of muscle damage (Filvaroff et al. 1994) .
In more severe forms of muscular dystrophy, such as DMD, the proliferation and activation of cells that act on inflammation are accentuated; however, the pool of cells responsible for regeneration is quickly exhausted, and the damaged skeletal muscle is progressively replaced by fat and fibrous tissue (Emery 2002) .
Although Tregs were largely absent in the muscle of wild-type mice and normal human muscle, with necrotic lesions and increasing of expression of interleukin-10 (IL-10) in mdx mice if we have a depletion of Tregs, the muscle injury and the severity of muscle inflammation is increased. Tregs modulate the progression of disease in MDX mice (Villalta et al. 2014) .
The Golden Retriever Muscular Dystrophy (GRMD) dog is the animal model that is most similar to human DMD. Because it is genetically homologous, it shares the human profile of severe myopathy and lethal clinical development. Clinically, it is characterized by severe alterations in the skeletal musculature that result in the early death of the affected individual. GRMD is used as an experimental model for studies of new therapeutic proposals and for studies (Yang et al. 2012) aiming to improve the understanding of the pathophysiology of the disease (Collins and Morgan 2003) . Future studies of different cellular populations and the factors that produce them will be crucial for the development of new therapeutic strategies, alone or in combination with cellular therapy, and the improvement of treatments for degenerative muscular diseases (Collins and Morgan 2003) . In particular, it is extremely IMMUNOPHENOTYPING LYMPHOCYTE IN MUSCULAR DYSTROPHY 2979
FLOW CYTOMETRY -IMMUNOPHENOTYPING AND QUANTIFICATION OF LYMPHOCYTES
The collected blood was diluted in PBS (phosphate buffer solution) and deposited on a Ficoll-Paque® density gradient. The gradient was centrifuged at 400 x G for 20 minutes at 20°C to separate mononuclear cells at the 1077 interface. These cells were washed in PBS, and the cellular concentration and viability were then determined using Trypan Blue. The cells were then adjusted to 1x10 6 cells per mL and incubated for 30 minutes in 1 µL of primary monoclonal anti-CD4 (Novus Biologicals®), anti-CD5 (Novus Biologicals®) and anti-CD8 (Novus Biologicals®) antibodies. The cells were then washed twice in PBS and incubated with the secondary monoclonal antibody conjugated with anti-IgG1 and anti-IgG2a FITC (BioLegend®) for 30 minutes while protected from the light. Next, the cells were washed once again with PBS and acquired using the flow cytometer (FacsCalibur -BD®). For this assay, we acquired 50,000 events, and the analysis was performed using the FlowJo® software.
ELECTROPHORESIS OF SERUM PROTEINS
The polyacrylamide gel required for electrophoretic fractionation using the SDS-PAGE technique important to understand how the inflammatory response occurs in this experimental model and how the immune system behaves in response to tissue injury. Despite the importance of this model of muscular dystrophy, we lack defined parameters for acute phase proteins and immunoglobulins as well as lymphocyte immunophenotyping for GRMD, which would assist us in understanding the muscular inflammatory response that results in the necrosis and substitution of this tissue. We followed our previous approach using morphological tools to characterize different phenotypes in GRMD dogs (Ambrosio et al. 2009 , Gaiad et al. 2011 , Araujo et al. 2013 ). In addition, we are to show some expression of these cells since birth of GRMD dogs until adult age starting among 10 months.
MATERIALS AND METHODS

EXPERIMENTAL GROUPS
Our GRMD facilities (Kennel GRMD-Brazil) are located at São Paulo University, Faculty of Veterinary Medicine and Animal Science. Our experiment was approved by Veterinary Ethic Committee for right use of experimentation animals at same Institution, protocol number 1640/2009. Our plan was to study normal Golden Retriever dogs (GR group) and Golden Retriever dogs affected by muscular dystrophy (GRMD group). Each group (Table I) consisted of three subgroups allocated according to age: umbilical cord blood from neonate animals (GR I n=7 and GRMD I n=4), peripheral blood from young animals between 2 and 3 months of age (GR II n=7 and GRMD II n=4) and peripheral blood from adult animals (GR III n=14 and GRMD III n=14). Due to the small volume of blood obtained from the umbilical cords, it was not possible to evaluate lymphocyte immunophenotyping parameters for groups GR I and GRMD I. was prepared using 15 mL of distilled water; 3.0 mL of 2 M tris-base / 1 M glycine, pH 9.0; 7.5 mL of 40% polyacrylamide; 1.5 mL of 2% bisacrylamide; 1.5 mL of glycerol; 0.6 mL of 0.5 M ethylenediaminetetraacetic acid, pH 8.3 and 0.6 mL of sodium dodecyl sulfate (SDS). The gel polymerization was induced by the addition of 15.0 µL of tetramethylethylenediamine (TEMED) and 0.3 mL of 10% ammonium persulfate. The plate containing the gel was placed on an appropriate support in contact with an upper vat that contained buffer solution at pH 8.5. A 5 uL aliquot of this sample was deposited on the gel and subjected to an electrical current of 50 mA from an appropriate source. Once the separation was completed, the gel was stained and destained ( Figure 1 ). The molecular weights and concentrations of the protein fractions were determined by densitometry (Shimadzu CS-9301 densitometer). For the accurate identification of the blood serum protein fractions, a standard marker for molecular weights and purified proteins was used for each electrophoresis run. From this point on, the values for each protein were converted to percentages relative to the total protein value for each dog.
ANALYSIS OF RESULTS
The results obtained were evaluated by analysis of variance and comparison of means using Student's t test and for a variance scheme for repeated measurements. In cases of significant differences, the results were subjected to the Tukey test for means comparison with a level of probability of 5%. The Statistical Analysis System (SAS) was used for this analysis.
RESULTS
IMMUNOPHENOTYPING AND QUANTIFICATION OF LYMPHOCYTES
All of the dogs studied had lymphocyte concentrations within the limits of normality according to the leukocyte count. In the dot plot in Figure 2 , we show the gate, which refers to the population of lymphocytes in the dogs' peripheral blood that were identified using flow cytometry and selected for immunophenotyping and lymphocyte quantification ( Figure 3) . When comparing the averages, we observed no statistically significant differences between the CD8+ lymphocyte subpopulations of the groups studied. The CD4+ and CD5+ lymphocyte subpopulations were significantly higher in the GRMD III group compared to the GR III group (Figure 4 ). The CD4+ :CD8+ ratio for the GRMD III group was greater than that of the GR III group (2.189 and 1.717, respectively) (Table II) . When examining the differences, and the make-up, between the groups, we considered age (between groups I, II and III) and disease status (GR and GRMD) as possible factors associated with statistical significance.
The proteins whose showed alterations related to the disease were C-reactive protein, alphaantitrypsin, haptoglobin and acid glycoprotein.
The serum concentrations of all proteins belonging to the GR I and GRMD I groups were significantly lower than those of the other groups. The only acute phase proteins that differed significantly between the two groups was C-reactive protein with the higher concentration observed in group GRMD I ( Figure 5 ). Although the difference in the concentration of this protein was not significantly different between groups GRMD II and GRMD III, group GRMD III was more similar to groups GR II and GR III (Table II) .
As shown in Table II , the average serum levels for alpha-1-antitrypsin in groups GR II and GR III did not differ significantly from each other but did differ significantly from groups GRMD II and GRMD III, which showed the highest serum concentrations of this protein ( Figure 5 ). Haptoglobin was most highly expressed by animals in group GRMD II, and the average levels in these animals differed significantly from animals in the other groups. Groups GR II and GR III were not significantly different. Similarly, group GRMD II had the highest serum concentration for acid glycoprotein, differing significantly from the other groups. Groups GR II and GR III were statistically similar to each other. Group GRMD III differed significantly from the others, with the lowest serum concentration (Table II; Figure 5 ).
In analyzing the proteins identified in the umbilical cord blood of affected and healthy animals, it is evident that the acute phase proteins that differed significantly between these spencergroups was C-reactive protein. For animals with ages between two and three months that were either normal or affected by dystrophy, we note that the acute phase proteins that differed significantly were an C-reactive protein, alpha-1-antitrypsin, haptoglobin, acid glycoprotein. Further, in adult animals, whether affected or normal, we observed that the proteins that differed significantly were the alpha-1-antitrypsin and acid glycoprotein.
DISCUSSION
The average absolute values obtained for serum proteins at birth were below levels reported in adult animals, confirming data reported by Barsanti et al. (1997) . Similarly, the values found in our study confirm the reports of Godoy et al. (2007) , which document low levels of gamma globulins in domestic animals at birth. The reduced level of total serum protein from umbilical cord blood is primarily due to the small quantities of gamma globulin found in the blood of dogs at birth. In domestic carnivores, although a small amount of IgG passes through the placenta, the larger portion is acquired through the ingestion of colostrums. Transplacental passage takes place via the endotheliochorial placenta in dogs, where the chorionic epithelium is in contact with the endothelium of the maternal capillaries (Chucri et al. 2010 ). An increase in protein concentrations in the acute phase has been reported in various infectious and inflammatory processes in humans and animals (Kurabayashi et al. 2003) . In this study, we showed that the acute phase proteins were enlarged in dystrophic animals at least in one of the age groups.
Haptoglobin is a positive acute phase protein that is found at moderately high levels in dogs (Conner et al. 1988) . However, many studies show that changes in the concentration of haptoglobin can act as a diagnostic and prognostic parameter for inflammatory processes (Martinez-subiela et al. 2002) . Harvey and West (1987) have previously reported that the average concentration of haptoglobin in healthy dogs is 104 mg/dL, although Solter et al. (1991) obtained a value of 56 mg/dL. Eckersall (2008) state that the concentration of haptoglobin in healthy dogs falls between 0 and 3000 mg/dL, while Martinez-Subiela et al. (2004) report values between 30 and 180 mg/dL (Eckersall et al. 1999) . Here, we corroborate the findings of the abovementioned authors, as well as the findings of Pereira et al. (2010) , who report an average serum concentration of haptoglobin in healthy dogs of approximately 28.72 mg/dL, by reporting an average hepatoglobin concentration of 31.14 mg/ dL for healthy dogs and no significant difference in hepatoglobin concentration for affected dogs. Our results for normal adult dogs did not agree with the data reported by Eckersall et al. (1999) who observed serum levels for haptoglobin between 10 and 20 mg/dL for normal canines, equines and swines. In addition, they report that serum haptoglobin may increase to 50 mg/dL in the presence of inflammatory and infectious diseases, corroborating our results, wherein affected dogs with ages varying between 2 and 3 months of age had a concentration of 47.267 mg/dL (Fournier et al. 2000) .
Acid glycoprotein is a positive acute-phase protein. In humans, the pharmacokinetics, efficacy and toxicology of basic drugs are influenced by variations in acid glycoprotein (Matsushima et al. 2000) . Ganrot (1973) evaluated alpha-1 acid glycoprotein in normal dogs and observed serum levels of 50 to 60 mg/dL. Upon induction of the inflammatory process, this acute phase protein showed a rapid and significant increase, with a half-life of approximately 5.5 days. Similarly, Dello et al. (1988) reported values of 47 mg/dL for normal dogs and 285 mg/dL for animals with inflammatory disease. Our data for normal dogs (34.77 mg/dL) do not corroborate these results. With respect to affected animals, the animals that were 2 to 3 months of age showed an increased serum concentration in comparison to normal dogs of the same age or to adults. Adult animals affected by dystrophy had reduced levels of acid glycoprotein. Kurabayashi et al. (2003) evaluated the serum levels of acid glycoprotein in healthy Beagle dogs -males and females, ages varying from 3 to 72 months. In their study, they did not observe alterations related to sex or age; likewise, our study did not find alterations related to age, with the exception of the umbilical cord blood. The values found by the abovementioned authors varied between 4.00 mg/dL and 83.30 mg/dL, while in our study, the serum levels varied from 19.27 mg/dL to 41.89 mg/dL for healthy animals more than 2 months of age. For umbilical cord blood, Kurabayashi et al. (2003) reported the presence of acid glycoprotein at a level lower than 4.00 mg/dL, congruent with our finding that the average serum levels in umbilical cord blood were 3.29 mg/dL for normal dogs and 4.12 mg/dL for affected dogs.
Yuki et al. (2010), in a study evaluating the serum concentrations of clinically healthy puppies and adults, observed that neonate dogs have approximately 30% of the glycoprotein of adult dogs. In our study, with the exception of the umbilical cord blood, which had approximately 10% of the average concentration for normal adult dogs, there was no significant difference between normal young and adult animals. Our data corroborate that of Hayashi et al. (2001) , who found that healthy dogs of 3 months of age did not show higher serum levels than did adult animals. However, a similar pattern was not observed for the affected animals in our study. Additionally, the authors report that mongrel dogs that had access to the outdoors had different concentrations of acid glycoprotein when compared to Beagle dogs that live in houses, with rates of 36.40 mg/dL and 28.60 mg/dL, respectively. The authors suggested that these differences may be related to the undomesticated lifestyle of mongrel dogs. We observed a higher serum concentration of 38.52 mg/dL in the normal Golden Retriever dogs evaluated here.
As has been previously stated, animals aged between 2 and 3 months affected by muscular dystrophy had serum concentrations of acid glycoprotein higher than the values found for healthy animals, showing that the progressive profile of dystrophy alters the serum concentration of this protein. Acid glycoprotein is considered to be an important marker for inflammation and is thought to perform an important function in tissue repair caused by inflammation (Fournier et al. 2000) . It is, therefore, an essential protein that should be evaluated in animals affected by muscular dystrophy, a disease in which muscle becomes more susceptible to injury in the absence of dystrophin at the sarcoplasmic membrane, resulting in the activation of endogenous proteases and, consequently, the inflammatory cascade.
The principal function of alpha-1-antitrypsin is to inhibit neutrophilic elastase, preventing the occurrence of tissue damage (Stoller and Aboussouan 2005) . In our study, this protein was present at an increased level in affected animals with ages varying between 2 and 3 months and adults. Alpha-1-antitrypsin increases immediately after infection or inflammation (Carapeto et al. 2006) , although infection is not corroborated by our results. We report the increase of this protein in adult affected animals, whose the inflammatory process no longer occurs in an acute way because of the progressive nature of the disease.
C-reactive protein, which is associated with various inflammatory and pathological processes, has been widely studied in dogs (Ljungvall et al. 2010 ). According to Martinez-Subiela et al. (2004) , serial concentrations of this protein vary between 0.022 and 0.404 mg/dL, and Otabe et al. (1998) report a value of approximately 0.84 mg/dL. Pereira et al. (2010) report an average concentration for normal dogs of 25.52 mg/dL, corroborating our result, which is 25.39 mg/dL for normal dogs. In addition, it is important to emphasize that, in umbilical cord blood, there is a significant difference in the concentration of C-reactive protein between affected and healthy animals. We therefore infer that this protein is associated with the disease prior to birth.
Changes in acute phase proteins reflect the acute responses to muscle injuries that occur progressively in dystrophic dogs, especially in young dystrophic animals. We can infer that these animals exhibit protein alterations in response to tissue injury, as is reported for various inflammatory processes related to other pathologies.
The modulation of lymphocytes is crucial for maintenance of the immune system. Normally, viral infections, immune deficiency diseases and other infectious diseases produce abnormal changes in the levels of lymphocytes (Veazey et al. 2003) . In addition, the inflammatory process alters cell populations that act on the immune system through the activation and directed migration of many different cells, chiefly neutrophils and macrophages, from the bloodstream to the sites of injury (Ahmad et al. 2010) .
In the present study, we used flow cytometry stainings to phenotype mononuclear leukocytes in peripheral blood of normal and affected by muscular dystrophy adult animals. Using these stainings, we demonstrated that the animals affected by muscular dystrophy exhibited CD4
+ and CD5 + lymphocyte percentages that were significantly higher than those found in healthy animals, which additionally had a lower CD4:CD8 ratio. Byrne et al. (2000) , although the CD4:CD8 ratio we observed was 1.71, which is consistent with Byrne et al. (2000) . This ratio for CD4:CD8 is likewise consistent with the data of Rivas et al. (1995) , who reported a ratio of 1.7. Rivas et al. (1995) similarly reported CD4+ and CD8+ ranges in normal dogs of 27 to 33% and 17 to 18%, respectively, that were higher than those reported here.
According to Greeley et al. (1996) , older dogs exhibit a lower percentage of CD4 + cells when compared to younger dogs, with values of 30.9% and 45.1%, respectively. A reduction in the percentage of CD8 concomitantly increases the average CD4:CD8 ratio, which is 3.17 for young dogs and 2.21 for adult dogs. In comparison, the CD4:CD8 ratio for the group of dogs was 1.74, consistent with our results for Golden Retriever dogs. Other animal model of muscular dystrophy presented a large number of increased versus decreased protein species in mdx-4cv serum by comparative spectrometry mass tolls (Murphy et al. 2017) . The interest of this study is related to the extent of inflammatory response in muscular dystrophy, it can, after a time of injury be detrimental, resulting in the replacement of muscle tissue through a progressive inflammation. Thus, to understand how this process occurs, knowing the behavior of some parameters involved in the inflammatory process becomes of extreme importance in study with preclinical cell therapy, medication or genetics.
Thus, we can infer that the progressive process of dystrophy is related to alterations in the cell populations that constitute the immune systems of patients. The muscles of these patients become more susceptible to injuries due to the absence of dystrophin, and when injuries occur, a release of cytokines stimulates liver cells to secrete acute phase proteins and to promote the co-stimulation of T lymphocytes. Thus, we suggest that the data reported are the consequence of the inflammatory response generated by muscular injury in GRMD.
